Come up with a name for your new list and we'll add to it:
Absynth Biologics raised a round of funding on April 14, 2014. Investors include
Regional Growth Fund.
Absynth Biologics has been created with the initial goal of developing immunological prophylaxis and therapy to combat bacterial infections. Absynth's strategy is to exploit the characterization of ca…